Table 2 Presenting vital signs and laboratory data in the propensity-matched cohort of patients hospitalized with COVID-19.
Ā | Statins use (nā=ā648) | No statins use (nā=ā648) | p value |
---|---|---|---|
Presenting vital signs | |||
Ā āTemperature | 99.0 (98.2ā100.1) | 98.8 (98.2ā100.0) | 0.21 |
Ā Ā āāFever (temperatureā>ā100.4ā°F) | 139 (21.4%) | 129 (19.9%) | 0.54 |
Ā āRespiratory rate | 18.0 (18.0ā20.0) | 19.0 (18.0ā22.0) | 0.19 |
Ā Ā āāTachypnea (RRā>ā21) | 143 (22.1%) | 186 (28.7%) | <0.01 |
Ā āOxygen saturation | 94.0 (90.0ā97.0) | 94.0 (89.0ā96.0) | 0.06 |
Ā Ā āāHypoxia (Oxygen saturation <92%) | 186 (28.7%) | 204 (31.5%) | 0.30 |
Ā āSystolic blood pressure | 123.0 (109.0ā139.0) | 124.0 (110.0 ā 141.0) | 0.38 |
Ā āDiastolic blood pressure | 72.0 (64.8ā81.0) | 73.0 (65.0ā81.0) | 0.08 |
Ā Ā āāHypotension (SBPā<ā90āmmHg) | 25 (3.9%) | 15 (2.3%) | 0.15 |
Ā āHeart rate | 96.0 (86.0ā109.3) | 98.0 (86.0ā110.3) | 0.47 |
Ā Ā āāTachycardia (HRā>ā100) | 270 (41.7%) | 287 (44.3%) | 0.37 |
Presenting laboratory values | |||
Ā āWhite blood cell count (103/µL) | 7.6 (5.5ā10.3) | 8.1 (5.8ā11.6) | <0.01 |
Ā āPlatelet count (103/µL) | 235.0 (159.0ā329.0) | 224.0 (149.0ā314.0) | 0.43 |
Ā āCreatinine (mg/dL) | 1.8 (1.1ā3.3) | 1.9 (1.1ā3.8) | 0.19 |
Ā āAST (U/L) | 81.0 (44.8ā126.3) | 84.0 (45.5ā142.5) | 0.32 |
Ā āALT (U/L) | 62.5 (33.3ā95.8) | 60.5 (33.3ā107.3) | 0.43 |
Ā āAlbumin (g/dL) | 3.6 (2.8ā4.4) | 3.6 (2.7ā4.4) | 0.93 |
Ā āLactate (mmol/L) | 2.8 (1.6ā4.2) | 3.1 (1.8ā4.7) | 0.35 |
Ā āHs-Troponin (ng/L) | 76.5 (34.3ā164.8) | 88.0 (39.8ā162.3) | 0.50 |
Ā āD-dimer (µg/mL) | 2.1 (1.1ā3.7) | 2.5 (1.3ā5.0) | 0.37 |
Ā āFerritin (ng/mL) | 667.8 (335.1ā1248.5) | 714.2 (368.2ā1299.0) | 0.74 |
Ā āESR (mm/h) | 67.5 (37.8ā97.3) | 66.5 (36.3ā96.8) | 0.84 |
Ā āCRP (mg/L) | 100.0 (46.2ā168.5) | 120.7 (61.2ā194.9) | <0.001 |